BioWorld MedTech

March 6, 2017

Boston Scientific receives partial win in TAVR infringement case against Edwards Lifesciences

Boston Scientific Corp. received a split decision from a U.K. patent court in its transcatheter aortic valve replacement (TAVR) patent infringement lawsuit against Edwards Lifesciences Corp. Read More

Hyperpolarized MRI surpasses PET-CT revealing human biology in vivo

Start up Freenome raises $65M to back liquid biopsy created via machine learning

Device deals climb with a focus on cancer, cardiovascular markets

IDEs seen as ideal for tests of patient-reported outcomes

Appointments and advancements

Financings

Product briefs

MDD's Stock Report

Regulatory front

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 16, 2025.

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

CT scan of brain showing subdural hematoma

FDA greenlights Medtronic Onyx subdural hematoma treatment

BioWorld MedTech

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...